Healthpeak Properties/$DOC
1D1W1MYTD1Y5YMAX
Capital at risk
About Healthpeak Properties
Healthpeak owns a diversified healthcare portfolio of nearly 700 in-place properties spread across mainly medical office and life science assets, plus a small portfolio of senior housing properties owned through the company's equity investment in Janus Living.
- Ticker
- $DOC
- Sector
- Real Estate
- Primary listing
- NYSE
- Employees
- 411
- Headquarters
- Denver, United States
- Website
- www.healthpeak.com
DOC Metrics
BasicAdvanced
$14B
57.72
$0.35
1.00
$1.22
6.05%
Price and volume
Market cap
$14B
Beta
1
52-week high
$22.95
52-week low
$15.70
Average daily volume
4.6M
Dividend rate
$1.22
Financial strength
Current ratio
2.286
Quick ratio
0.672
Long term debt to equity
0.892
Total debt to equity
1.087
Dividend payout ratio (TTM)
347.72%
Interest coverage (TTM)
1.47%
Profitability
EBITDA (TTM)
1,561.053
Gross margin (TTM)
57.46%
Net profit margin (TTM)
8.25%
Operating margin (TTM)
16.84%
Effective tax rate (TTM)
1.32%
Revenue per employee (TTM)
$7,180,000
Management effectiveness
Return on assets (TTM)
1.50%
Return on equity (TTM)
3.04%
Valuation
Price to earnings (TTM)
57.724
Price to revenue (TTM)
4.741
Price to book
1.77
Price to tangible book (TTM)
1.97
Price to free cash flow (TTM)
11.361
Free cash flow yield (TTM)
8.80%
Free cash flow per share (TTM)
1.775
Dividend yield (TTM)
6.05%
Forward dividend yield
6.05%
Growth
Revenue change (TTM)
5.52%
Earnings per share change (TTM)
46.76%
3-year revenue growth (CAGR)
11.71%
10-year revenue growth (CAGR)
5.18%
3-year earnings per share growth (CAGR)
-29.01%
10-year earnings per share growth (CAGR)
9.13%
3-year dividend per share growth (CAGR)
0.55%
10-year dividend per share growth (CAGR)
-6.06%
What the Analysts think about DOC
Majority rating from 19 analysts.
| Month | Buy | Hold | Sell | Analysts | Majority rating |
|---|---|---|---|---|---|
| July 2023 | 11 | 8 | 0 | 19 | Buy |
| August 2023 | 11 | 7 | 0 | 18 | Buy |
| September 2023 | 11 | 7 | 0 | 18 | Buy |
| October 2023 | 8 | 6 | 0 | 14 | Buy |
| November 2023 | 8 | 6 | 2 | 16 | Buy |
| December 2023 | 8 | 6 | 2 | 16 | Buy |
| January 2024 | 9 | 6 | 2 | 17 | Buy |
| February 2024 | 10 | 6 | 1 | 17 | Buy |
| March 2024 | 8 | 8 | 1 | 17 | Buy |
| April 2024 | 12 | 7 | 0 | 19 | Buy |
| May 2024 | 13 | 6 | 0 | 19 | Buy |
| June 2024 | 13 | 6 | 0 | 19 | Buy |
Bulls say / Bears say
Healthpeak raised full-year 2026 FFO as Adjusted guidance by $0.02 to $1.73–$1.77 per share after beating Q2 expectations on stronger same-store NOI and leasing momentum (BusinessWire).
Formed a strategic $2.1 billion JV with Brookfield, contributing an 86-property, 5.6 million sq ft outpatient portfolio and securing $1.025 billion in proceeds to strengthen the balance sheet (BusinessWire).
Executed 1.6 million sq ft of new and renewal leases in Outpatient Medical and Lab, with an additional ~1.08 million sq ft under LOIs, underscoring robust tenant demand across core segments (BusinessWire).
Lab same-store Adjusted NOI contracted by 3.2% year-over-year in Q2 2026, signaling continued pressure on the life science portfolio (BusinessWire).
Lab segment occupancy remained low at 78.5% as of June 30, 2026—well below the 90.7% in Outpatient Medical—reflecting elevated vacancy and ongoing leasing challenges (BusinessWire).
Net debt to Adjusted EBITDAre was 4.7x in Q2 2026, an elevated leverage level that may limit financial flexibility amid a higher interest rate environment (BusinessWire).
Data summarised monthly by Lightyear AI. Last updated on 20 Aug 2026.
Upcoming events
DOC News
AllArticlesVideos
Funds containing DOC
AllUSDGBPEUR
Fund name | Fund size | $DOC weighting |
|---|---|---|
iShares Developed Markets Property Yield$IDWP | $1.2B | 0.84% |
iShares Developed Markets Property Yield£IWDP | £859M | 0.84% |
iShares S&P 500 Equal Weight€O4J0 | €4.3B | 0.19% |
iShares S&P 500 Equal Weight£EWSP | £3.7B | 0.19% |
iShares MSCI USA Small Cap ESG Enhanced CTB€SXRG | €2.8B | 0.16% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.